Market Overview

Egalet Tells Benzinga 'We Don't Have Any Idea Of Timing' Related To FDA Decision On ARYMO ER; BZ Note: Notable Analyst Tells Benzinga Typical Delay-To-Approval On Opiods Runs 2-4 Weeks

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for EGLT

DateFirmActionFromTo
Mar 2016Janney CapitalInitiates Coverage onNeutral
Nov 2015Cantor FitzgeraldInitiates Coverage onBuy
May 2015GuggenheimInitiates Coverage onBuy

View More Analyst Ratings for EGLT
View the Latest Analyst Ratings

Posted-In: Analyst Color Biotech News FDA Exclusives Analyst Ratings General

 

Related Articles (EGLT)